AXCELLA HEALTH INC (AXLA)
US05454B2043 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A 277.21% | |||||||
| EBITDA YoY % growth | -27.53M | -32.83M -19.25% | -56.78M -72.95% | -53.42M 5.92% | -61.56M -15.24% | -72.39M -17.59% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -28.92M | -33.9M -17.22% | -57.44M -69.44% | -53.84M 6.27% | -61.85M -14.88% | -72.8M -17.70% | N/A 78.42% | N/A -0.57% | N/A -3.84% | N/A -338.15% | N/A -43.36% | N/A 0.22% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | -4.81 | -1.87 61.12% | -12.73 -580.75% | -38.25 -200.47% | N/A 86.67% | N/A | N/A -5.00% | N/A -319.05% | N/A -39.77% | N/A 3.25% |
All data in USD
| Q3 / 23 | Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.28 85.00% | -1.28 84.55% | -1.28 -2.00% | -1.28 -2.00% | -1.28 | -1.28 |
| Revenue Q2Q % growth | ||||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -3.908M 77.14% | -3.919M 76.62% | -3.931M 5.96% | -3.943M -11.39% | -3.956M -1.23% | -3.967M -1.22% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2023 Q2Q % growth | -1.25 87.50% | -1.53 | 0.28 | 18.30% |
| Q1 2023 Q2Q % growth | -1.25 89.13% | -4.08 | 2.83 | 69.36% |
| Q4 2022 Q2Q % growth | -8.25 28.26% | -7.65 | -0.60 | -7.84% |
| Q3 2022 Q2Q % growth | -8.50 -1,973.17% | -9.73 | 1.23 | 12.66% |
| Q2 2022 Q2Q % growth | -10.00 -2,280.95% | -9.69 | -0.31 | -3.20% |
| Q1 2022 Q2Q % growth | -11.50 -2,775.00% | -9.95 | -1.55 | -15.64% |
| Q4 2021 Q2Q % growth | -11.50 -2,775.00% | -11.40 | -0.10 | -0.86% |
| Q3 2021 Q2Q % growth | -0.41 -20.59% | -0.47 | 0.06 | 12.24% |
| Q2 2021 Q2Q % growth | -0.42 12.50% | -0.44 | 0.02 | 3.74% |
| Q1 2021 Q2Q % growth | -0.40 38.46% | -0.43 | 0.03 | 5.88% |
| Q4 2020 Q2Q % growth | -0.40 41.18% | -0.37 | -0.03 | -8.60% |
| Q3 2020 Q2Q % growth | -0.34 54.67% | -0.42 | 0.08 | 18.20% |
| Q2 2020 Q2Q % growth | -0.48 49.47% | -0.57 | 0.09 | 16.27% |
| Q1 2020 Q2Q % growth | -0.65 73.25% | -0.87 | 0.22 | 25.68% |
| Q4 2019 Q2Q % growth | -0.68 | -0.75 | 0.07 | 9.50% |
| Q3 2019 Q2Q % growth | -0.75 | -0.72 | -0.03 | -3.56% |
| Q2 2019 Q2Q % growth | -0.95 | -0.66 | -0.29 | -44.40% |
| Q1 2019 Q2Q % growth | -2.43 | -0.50 | -1.93 | -389.52% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -2400% | 0% | -2172.73% |
| Revenue | N/A | N/A | N/A | N/A |